Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen A Cochrane

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Chembiochem : a European Journal of Chemical Biology|January 3, 2014
Biochemical, structural, and genetic characterization of tridecaptin A₁, an antagonist of Campylobacter jejuniChristopher T Lohans, Marco J van Belkum, Stephen A Cochrane, et al.
ACS Central Science|March 4, 2020
Observation of the Unbiased Conformers of Putative DNA-Scaffold RibosugarsCamilla Calabrese, Iciar Uriarte, Aran Insausti, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 11, 2024
A classic antibiotic reimagined: Rationally designed bacitracin variants exhibit potent activity against vancomycin-resistant pathogensNed P Buijs, Halana C Vlaming, Ioli Kotsogianni, et al.
Chembiochem : a European Journal of Chemical Biology|September 26, 2019
Dissecting the Binding Interactions of Teixobactin with the Bacterial Cell-Wall Precursor Lipid IISorina Chiorean, Isaac Antwi, Daniel W Carney, et al.
ACS Central Science|January 27, 2025
Lipid-Modulated, Graduated Inhibition of N-Glycosylation Pathway Priming Suggests Wide Tolerance of ER Proteostasis to StressAndrew M Giltrap, Niamh Morris, Yin Yao Dong, et al.
Chemical Science|April 18, 2022
Synthetic studies with the brevicidine and laterocidine lipopeptide antibiotics including analogues with enhanced properties and <i>in vivo</i> efficacyKarol Al Ayed, Ross D Ballantine, Michael Hoekstra, et al.
Journal of Medicinal Chemistry|September 16, 2025
Novltex: A New Class of Antibiotics with Potent Activity against Multidrug-Resistant Bacterial Pathogens─Design, Synthesis, and Biological EvaluationEsra Malkawi, Anish Parmar, Sanjit Das, et al.
ACS Chemical Biology|April 11, 2024
Discovery and Derivatization of Tridecaptin Antibiotics with Altered Host Specificity and Enhanced BioactivityNataliia V Machushynets, Karol Al Ayed, Barbara R Terlouw, et al.
ACS Chemical Biology|May 7, 2024
Computational Design of Cyclic Peptide Inhibitors of a Bacterial Membrane Lipoprotein PeptidaseTimothy W Craven, Mark D Nolan, Jonathan Bailey, et al.
Nature Microbiology|May 23, 2024
Host defence peptide plectasin targets bacterial cell wall precursor lipid II by a calcium-sensitive supramolecular mechanismShehrazade Jekhmane, Maik G N Derks, Sourav Maity, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Chembiochem : a European Journal of Chemical Biology|January 3, 2014
Biochemical, structural, and genetic characterization of tridecaptin A₁, an antagonist of Campylobacter jejuniChristopher T Lohans, Marco J van Belkum, Stephen A Cochrane, et al.
ACS Central Science|March 4, 2020
Observation of the Unbiased Conformers of Putative DNA-Scaffold RibosugarsCamilla Calabrese, Iciar Uriarte, Aran Insausti, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 11, 2024
A classic antibiotic reimagined: Rationally designed bacitracin variants exhibit potent activity against vancomycin-resistant pathogensNed P Buijs, Halana C Vlaming, Ioli Kotsogianni, et al.
Chembiochem : a European Journal of Chemical Biology|September 26, 2019
Dissecting the Binding Interactions of Teixobactin with the Bacterial Cell-Wall Precursor Lipid IISorina Chiorean, Isaac Antwi, Daniel W Carney, et al.
ACS Central Science|January 27, 2025
Lipid-Modulated, Graduated Inhibition of N-Glycosylation Pathway Priming Suggests Wide Tolerance of ER Proteostasis to StressAndrew M Giltrap, Niamh Morris, Yin Yao Dong, et al.
Chemical Science|April 18, 2022
Synthetic studies with the brevicidine and laterocidine lipopeptide antibiotics including analogues with enhanced properties and <i>in vivo</i> efficacyKarol Al Ayed, Ross D Ballantine, Michael Hoekstra, et al.
Journal of Medicinal Chemistry|September 16, 2025
Novltex: A New Class of Antibiotics with Potent Activity against Multidrug-Resistant Bacterial Pathogens─Design, Synthesis, and Biological EvaluationEsra Malkawi, Anish Parmar, Sanjit Das, et al.
ACS Chemical Biology|April 11, 2024
Discovery and Derivatization of Tridecaptin Antibiotics with Altered Host Specificity and Enhanced BioactivityNataliia V Machushynets, Karol Al Ayed, Barbara R Terlouw, et al.
ACS Chemical Biology|May 7, 2024
Computational Design of Cyclic Peptide Inhibitors of a Bacterial Membrane Lipoprotein PeptidaseTimothy W Craven, Mark D Nolan, Jonathan Bailey, et al.
Nature Microbiology|May 23, 2024
Host defence peptide plectasin targets bacterial cell wall precursor lipid II by a calcium-sensitive supramolecular mechanismShehrazade Jekhmane, Maik G N Derks, Sourav Maity, et al.
Pageof 5